Found: 14
Select item for more details and to access through your institution.
Ipragliflozin in combination with metformin for the treatment of Japanese patients with type 2 diabetes: ILLUMINATE, a randomized, double-blind, placebo-controlled study.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 304, doi. 10.1111/dom.12331
- By:
- Publication type:
- Article
Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 294, doi. 10.1111/dom.12428
- By:
- Publication type:
- Article
News and Views.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 313, doi. 10.1111/dom.12443
- By:
- Publication type:
- Article
Pharmacological interventions for preventing or delaying onset of type 2 diabetes mellitus.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 231, doi. 10.1111/dom.12401
- By:
- Publication type:
- Article
Efficacy and safety of teneligliptin, a dipeptidyl peptidase-4 inhibitor, combined with metformin in Korean patients with type 2 diabetes mellitus: a 16-week, randomized, double-blind, placebo-controlled phase III trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 309, doi. 10.1111/dom.12424
- By:
- Publication type:
- Article
Insulin is not insulin and a unit not a unit.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 217, doi. 10.1111/dom.12404
- By:
- Publication type:
- Article
Therapeutically interchangeable? A study of real-world outcomes associated with switching basal insulin analogues among US patients with type 2 diabetes mellitus using electronic medical records data.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 245, doi. 10.1111/dom.12407
- By:
- Publication type:
- Article
Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 285, doi. 10.1111/dom.12423
- By:
- Publication type:
- Article
Single-dose new insulin glargine 300 U/ml provides prolonged, stable glycaemic control in Japanese and European people with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 254, doi. 10.1111/dom.12415
- By:
- Publication type:
- Article
Low within- and between-day variability in exposure to new insulin glargine 300 U/ml.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 261, doi. 10.1111/dom.12416
- By:
- Publication type:
- Article
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes ( EDICT): a randomized trial
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 268, doi. 10.1111/dom.12417
- By:
- Publication type:
- Article
Regardless of the degree of glycaemic control, linagliptin has lower hypoglycaemia risk than all doses of glimepiride, at all time points, over the course of a 2-year trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 276, doi. 10.1111/dom.12419
- By:
- Publication type:
- Article
Diabetes, Obesity and Metabolism.
- Published in:
- 2015
- Publication type:
- Other
New treatments for diabetic retinopathy.
- Published in:
- Diabetes, Obesity & Metabolism, 2015, v. 17, n. 3, p. 219, doi. 10.1111/dom.12384
- By:
- Publication type:
- Article